Founded in 1885, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies and the largest private one. They are headquartered in Ingelheim am Rhein, Germany and employ over 47,700 people. The company has established a three year partnership with Google Quantum to research and implement use cases for quantum computing in pharmaceutical R&D, including molecular dynamics simulations. Boehringer Ingelheim’s newly established Quantum Lab and Google will work to combine Boehringer Ingelheim’s expertise in the field of computer-aided drug design and in silico modeling with Google’s expertise in quantum computers and algorithms. Computational chemistry for drug discovery and materials simulation is thought to be one of the leading applications that will leverage quantum computing capabilities because the required simulation models quickly become too complex for classical computers to simulate accurately. For more on this announcement, you can view the news release located on the Boehringer Ingelheim website located here.
January 12, 2021